Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 17, 2025 07:30 ET | Source: ProPhase Labs, Inc.

ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart™ Test in Detecting Esophageal Cancer

BE-Smart represents a significant advance in diagnosis and management of Esophageal disease that affects an estimated 60 million people in the United States Study shows >95% success rate,...
June 06, 2025 07:00 ET | Source: ProPhase Labs, Inc.

ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform

UNIONDALE, NY, June 06, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced...
May 31, 2023 09:15 ET | Source: Biostage, Inc.

Biostage Initiated Study Start-up Activities for Clinical Trial in Severe Esophageal Disease

HOLLISTON, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs...
July 01, 2019 09:00 ET | Source: Cernostics

Cernostics Announces Formation of Distinguished Medical Advisory Board Including Top Specialists in All Facets of Esophageal Disease

PITTSBURGH, PA, July 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cernostics, developer of next-generation cancer diagnostics and prognostics, today announced the formation of a distinguished...